查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1729415

日本医药第三方物流市场报告（按服务、温度控制和地区）2025-2033

Japan Pharmaceutical 3PL Market Report by Service, Temperature Control, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 121 Pages | 商品交期: 5-7个工作天内

价格
简介目录

2024 年，日本医药第三方物流市场规模达 59 亿美元。展望未来， IMARC Group预计到 2033 年市场规模将达到 152 亿美元，2025-2033 年期间的成长率 (CAGR) 为 10.26%。製药公司越来越关注其核心竞争力，如药物开发和研究，而不受分销和合规复杂要求的束缚，这主要推动了市场的成长。

医药产业的第三方物流（3PL）在优化药品製造商和分销商的供应链方面发挥关键作用。製药第三方物流供应商提供专业的物流服务，确保药品依照严格的监管标准进行储存、处理和运输，确保其功效和安全性。鑑于药品的关键性及其对病人健康的直接影响，此物流框架内对精确性、及时性和合规性有着内在的需求。如今，随着製药业努力应对全球化市场、不断增长的需求和复杂的监管环境，这些第三方物流供应商在应对这些挑战方面发挥着重要作用。透过整合先进技术、即时追踪和合规管理，医药第三方物流在製造商和最终用户之间架起了无缝桥樑，确保救命药物及时、以最佳状态到达目的地。

日本医药第三方物流市场趋势：

日本医药第三方物流市场以国家医疗保健供应链为特征，体现了效率、精确度和合规性。主要驱动因素之一是药品领域复杂的监管环境。由于对储存、运输和分销有严格的规定，许多製药公司选择将这些物流挑战外包给具备专业知识和基础设施的第三方物流供应商。技术融合是塑造市场的另一个趋势。物联网设备、人工智慧分析和区块链的兴起确保了整个药品供应链的即时监控、增强的安全性和透明的可追溯性。这不仅提高了效率，而且还最大限度地降低了假冒或违反合规性的风险。此外，由于日本地理环境复杂，且需要最后一哩的配送解决方案，特别是针对老化的农村人口，第三方物流供应商正在不断创新，以确保药品能够到达最偏远的地区。最后，持续的全球健康挑战凸显了强大而灵活的供应链的重要性。疫情引发的混乱使得製药公司更加依赖第三方物流合作伙伴来应对不确定性并确保供应的连续性。本质上，监管需求、技术进步、人口挑战和健康状况的结合预计将推动日本医药第三方物流市场在预测期内实现显着增长。

日本医药第三方物流市场区隔：

服务洞察：

  • 国内运输管理
  • 国际运输管理
  • 加值仓储和配送

温度控制见解：

  • 受控/冷链物流
  • 非受控/非冷链物流

竞争格局：

市场研究报告也对竞争格局进行了全面的分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争仪表板和公司评估象限等竞争分析。此外，也提供了所有主要公司的详细资料。一些关键参与者包括：

  • DHL
  • 联邦快递公司
  • 嘉里物流联网有限公司（顺丰速运有限公司）
  • 德迅
  • 日本通运株式会社
  • 铃研株式会社

本报告回答的关键问题：

  • 日本医药第三方物流市场迄今表现如何？未来几年将如何表现？
  • COVID-19 对日本医药第三方物流市场有何影响？
  • 日本医药第三方物流市场如何依服务划分？
  • 根据温度控制，日本医药第三方物流市场是如何分類的？
  • 日本医药第三方物流市场的价值链分为哪些阶段？
  • 日本医药第三方物流的关键驱动因素与挑战是什么？
  • 日本医药第三方物流市场的结构是怎么样的？主要参与者有哪些？
  • 日本医药第三方物流市场的竞争程度如何？

本报告回答的关键问题：

  • 日本医药第三方物流市场迄今表现如何？未来几年将如何表现？
  • COVID-19 对日本医药第三方物流市场有何影响？
  • 日本医药第三方物流市场如何依服务划分？
  • 根据温度控制，日本医药第三方物流市场是如何分類的？
  • 日本医药第三方物流市场的价值链分为哪些阶段？
  • 日本医药第三方物流的关键驱动因素与挑战是什么？
  • 日本医药第三方物流市场的结构是怎么样的？主要参与者有哪些？
  • 日本医药第三方物流市场的竞争程度如何？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：日本医药第三方物流市场 - 简介

  • 概述
  • 市场动态
  • 产业趋势
  • 竞争情报

第五章：日本医药第三方物流市场格局

  • 历史与当前市场趋势（2019-2024）
  • 市场预测（2025-2033）

第六章：日本医药品第三方物流市场-细分：依服务

  • 国内运输管理
    • 概述
  • 国际运输管理
    • 概述
  • 加值仓储和配送
    • 概述

第七章：日本医药品第三方物流市场-细分：依温度控制

  • 受控/冷链物流
    • 概述
  • 非受控/非冷链物流
    • 概述

第 8 章：日本医药第三方物流市场 - 竞争格局

  • 概述
  • 市场结构
  • 市场参与者定位
  • 最佳获胜策略
  • 竞争仪錶板
  • 公司评估象限

第九章：关键参与者简介

  • DHL
    • Business Overview
    • Services Offered
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • FedEx Corporation
    • Business Overview
    • Services Offered
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Kerry Logistics Network Limited (SF Express Co. Ltd.)
    • Business Overview
    • Services Offered
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Kuehne + Nagel
    • Business Overview
    • Services Offered
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Nippon Express Co. Ltd.
    • Business Overview
    • Services Offered
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Suzuken Co. Ltd.
    • Business Overview
    • Services Offered
    • Business Strategies
    • SWOT Analysis
    • Major News and Events

第 10 章：日本医药第三方物流市场 - 产业分析

  • 驱动因素、限制因素和机会
    • 概述
    • 驱动程式
    • 限制
    • 机会
  • 波特五力分析
    • 概述
    • 买家的议价能力
    • 供应商的议价能力
    • 竞争程度
    • 新进入者的威胁
    • 替代品的威胁
  • 价值链分析

第 11 章：附录

简介目录
Product Code: SR112025A17286

Japan pharmaceutical 3PL market size reached USD 5.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 15.2 Billion by 2033, exhibiting a growth rate (CAGR) of 10.26% during 2025-2033. The increasing focus of pharmaceutical companies on their core competencies, like drug development and research, without being encumbered by the intricate demands of distribution and compliance, is primarily driving the market growth.

Third-party logistics (3PL) in the pharmaceuticals sector plays a pivotal role in optimizing the supply chain for drug manufacturers and distributors. Pharmaceutical 3PL providers offer specialized logistics services, ensuring that medications are stored, handled, and transported under stringent regulatory standards, guaranteeing their efficacy and safety. Given the critical nature of pharmaceuticals and their direct impact on patient health, there's an inherent need for precision, timeliness, and compliance within this logistical framework. Today, as the pharmaceutical industry grapples with a globalized market, rising demand, and complex regulatory environments, these 3PL providers become instrumental in navigating these challenges. By integrating advanced technologies, real-time tracking, and compliance management, pharmaceutical 3PLs offer a seamless bridge between manufacturers and end-users, ensuring that lifesaving medications reach their destinations promptly and in optimal condition.

Japan Pharmaceutical 3PL Market Trends:

The Japan pharmaceutical 3PL market is characterized by the nation's healthcare supply chain, epitomizing efficiency, precision, and compliance. One of the primary drivers is the complex regulatory environment surrounding pharmaceuticals. With stringent guidelines on storage, transportation, and distribution, many pharma companies are opting to outsource these logistics challenges to 3PL providers equipped with specialized knowledge and infrastructure. Technological integration is another trend shaping the market. The rise of IoT devices, AI-driven analytics, and blockchain ensures real-time monitoring, enhanced security, and transparent traceability throughout the drug supply chain. This not only improves efficiency but also minimizes the risk of counterfeits or compliance breaches. Furthermore, with Japan's geographical intricacies and the need for last-mile delivery solutions, especially to its aging rural population, 3PL providers are innovating to ensure that medications reach even the most remote areas. Lastly, the ongoing global health challenges have underscored the importance of a robust and agile supply chain. The pandemic-induced disruptions have made pharmaceutical companies more reliant on 3PL partners to navigate uncertainties and ensure continuity of supply. In essence, the combination of regulatory demands, technological advancements, demographic challenges, and health scenarios are projected to propel the Japan pharmaceutical 3PL market for significant growth over the forecasted period.

Japan Pharmaceutical 3PL Market Segmentation:

Service Insights:

  • Domestic Transportation Management
  • International Transportation Management
  • Value-added Warehousing and Distribution

Temperature Control Insights:

  • Controlled/Cold Chain Logistics
  • Non-controlled/Non-Cold Chain Logistics

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the key players include:

  • DHL
  • FedEx Corporation
  • Kerry Logistics Network Limited (SF Express Co. Ltd.)
  • Kuehne + Nagel
  • Nippon Express Co. Ltd.
  • Suzuken Co. Ltd.

Key Questions Answered in This Report:

  • How has the Japan pharmaceutical 3PL market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan pharmaceutical 3PL market?
  • What is the breakup of the Japan pharmaceutical 3PL market on the basis of service?
  • What is the breakup of the Japan pharmaceutical 3PL market on the basis of temperature control?
  • What are the various stages in the value chain of the Japan pharmaceutical 3PL market?
  • What are the key driving factors and challenges in the Japan pharmaceutical 3PL?
  • What is the structure of the Japan pharmaceutical 3PL market and who are the key players?
  • What is the degree of competition in the Japan pharmaceutical 3PL market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Pharmaceutical 3PL Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Pharmaceutical 3PL Market Landscape

  • 5.1 Historical and Current Market Trends (2019-2024)
  • 5.2 Market Forecast (2025-2033)

6 Japan Pharmaceutical 3PL Market - Breakup by Service

  • 6.1 Domestic Transportation Management
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2019-2024)
    • 6.1.3 Market Forecast (2025-2033)
  • 6.2 International Transportation Management
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2019-2024)
    • 6.2.3 Market Forecast (2025-2033)
  • 6.3 Value-added Warehousing and Distribution
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2019-2024)
    • 6.3.3 Market Forecast (2025-2033)

7 Japan Pharmaceutical 3PL Market - Breakup by Temperature Control

  • 7.1 Controlled/Cold Chain Logistics
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2019-2024)
    • 7.1.3 Market Forecast (2025-2033)
  • 7.2 Non-controlled/Non-Cold Chain Logistics
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2019-2024)
    • 7.2.3 Market Forecast (2025-2033)

8 Japan Pharmaceutical 3PL Market - Competitive Landscape

  • 8.1 Overview
  • 8.2 Market Structure
  • 8.3 Market Player Positioning
  • 8.4 Top Winning Strategies
  • 8.5 Competitive Dashboard
  • 8.6 Company Evaluation Quadrant

9 Profiles of Key Players

  • 9.1 DHL
    • 9.1.1 Business Overview
    • 9.1.2 Services Offered
    • 9.1.3 Business Strategies
    • 9.1.4 SWOT Analysis
    • 9.1.5 Major News and Events
  • 9.2 FedEx Corporation
    • 9.2.1 Business Overview
    • 9.2.2 Services Offered
    • 9.2.3 Business Strategies
    • 9.2.4 SWOT Analysis
    • 9.2.5 Major News and Events
  • 9.3 Kerry Logistics Network Limited (SF Express Co. Ltd.)
    • 9.3.1 Business Overview
    • 9.3.2 Services Offered
    • 9.3.3 Business Strategies
    • 9.3.4 SWOT Analysis
    • 9.3.5 Major News and Events
  • 9.4 Kuehne + Nagel
    • 9.4.1 Business Overview
    • 9.4.2 Services Offered
    • 9.4.3 Business Strategies
    • 9.4.4 SWOT Analysis
    • 9.4.5 Major News and Events
  • 9.5 Nippon Express Co. Ltd.
    • 9.5.1 Business Overview
    • 9.5.2 Services Offered
    • 9.5.3 Business Strategies
    • 9.5.4 SWOT Analysis
    • 9.5.5 Major News and Events
  • 9.6 Suzuken Co. Ltd.
    • 9.6.1 Business Overview
    • 9.6.2 Services Offered
    • 9.6.3 Business Strategies
    • 9.6.4 SWOT Analysis
    • 9.6.5 Major News and Events

10 Japan Pharmaceutical 3PL Market - Industry Analysis

  • 10.1 Drivers, Restraints and Opportunities
    • 10.1.1 Overview
    • 10.1.2 Drivers
    • 10.1.3 Restraints
    • 10.1.4 Opportunities
  • 10.2 Porters Five Forces Analysis
    • 10.2.1 Overview
    • 10.2.2 Bargaining Power of Buyers
    • 10.2.3 Bargaining Power of Suppliers
    • 10.2.4 Degree of Competition
    • 10.2.5 Threat of New Entrants
    • 10.2.6 Threat of Substitutes
  • 10.3 Value Chain Analysis

11 Appendix